Status:
NOT_YET_RECRUITING
Multi-modal Intelligent Diagnosis System for Multiple Ophthalmic Diseases
Lead Sponsor:
Beijing Hospital
Conditions:
Retina Disease
Glaucoma
Eligibility:
All Genders
20-90 years
Brief Summary
Aiming at the problems of low image reading efficiency, crowded medical resources and fragmented cross-modal information of ophthalmic OCT and OCTA, a multimodal large model diagnostic framework for v...
Eligibility Criteria
Inclusion
- Diagnosed as macular degeneration, diabetic macular edema, retinal vein obstructive macular edema, high myopia, glaucoma or other clearly diagnosed ophthalmic diseases. The SS-OCT/SS-OCTA images of the patient are clear.
Exclusion
- The image quality is poor and difficult to analyze due to reasons such as refractive media opacity and poor coordination.
Key Trial Info
Start Date :
August 30 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2028
Estimated Enrollment :
5000 Patients enrolled
Trial Details
Trial ID
NCT07143851
Start Date
August 30 2025
End Date
June 30 2028
Last Update
August 27 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.